Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Control Trial of Intravenous Acetaminophen (OFIRMEV) for the Reduction of Intrapartum Maternal Fever and Fetal Tachycardia

NCT02625454 is registered in ClinicalTrials.gov with Richmond University Medical Center as lead sponsor.

NCT NCT02625454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02625454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Control Trial of Intravenous Acetaminophen (OFIRMEV) for the Reduction of Intrapartum Maternal Fever and Fetal Tachycardia
Lead sponsor
Richmond University Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2016
Completion date
October 31, 2019
Enrollment
168 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fever, oxidative stress